RecruitingPhase 3NCT07743450
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Sponsor: Ascletis Pharma (China) Co., Limited
Boise, ID · +83 more sites
2 recruiting type 2 diabetes studies with a site in Boise, ID.
Sponsor: Ascletis Pharma (China) Co., Limited
Boise, ID · +83 more sites
Sponsor: Eli Lilly and Company
Boise, ID · +40 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.